Prostate Cancer Ontology
Center for Systems Biology, Sichuan University West China Hospital, Sichuan China
跳过导航链接。
折叠 前列腺癌前列腺癌
展开 前列腺癌流行病学前列腺癌流行病学
展开 前列腺癌的诊断前列腺癌的诊断
折叠 前列腺癌的治疗前列腺癌的治疗
展开 延期治疗延期治疗
展开 外科手术外科手术
展开 放射疗法放射疗法
展开 冷冻疗法冷冻疗法
展开 激素疗法激素疗法
展开 化疗化疗
展开 去势抵抗性前列腺癌(CRPC)去势抵抗性前列腺癌(CRPC)
展开 转移性前列腺癌转移性前列腺癌
折叠 其他治疗方式其他治疗方式
展开 老年男性前列腺癌的治疗老年男性前列腺癌的治疗
折叠 局部前列腺癌除手术和放疗以外的其他初级治疗选择局部前列腺癌除手术和放疗以外的其他初级治疗选择
展开 局部前列腺癌患者的治疗后生活质量局部前列腺癌患者的治疗后生活质量
展开 根治性目的治疗后仅限PSA复发的治疗根治性目的治疗后仅限PSA复发的治疗
前列腺癌冷冻手术并发症
Preferred Name Complications of cryosurgery for primary treatment of prostate cancer
Definition Erectile dysfunction occurs in about 80% of patients and this remains a consistent complication of the CSAP procedure, independent of the generation of the system used. The complication rates described in third-generation cryosurgery include tissue sloughing in about 3%, incontinence in 4.4%, pelvic pain in 1.4% and urinary retention in about 2%. The development of fistula is usually rare, being < 0.2% in modern series. About 5% of all patients require transurethral resection of the prostate (TURP) for subvesical
obstruction.
Synonyms & Abbreviations Complications of cryosurgery for primary treatment of prostate cancer
ReferenceCode NA
ReferenceURL NA
PMID NA
Copyright (C) 2022 Institutes for Systems Genetics, Sichuan University West China Hospital. All Rights Reserved.